Exystat   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Malakoff France (2013)

Organization Overview

First Clinical Trial
2013
NCT03362684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Exystat